News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Oriol Mirallas: My Top 10 Drug Development Abstracts at ASCO25
Oriol Mirallas/X
May 30, 2025, 23:58

Oriol Mirallas: My Top 10 Drug Development Abstracts at ASCO25

Oriol Mirallas, Medical Oncology Specialist at Vall d’Hebron Institute of Oncology, shared a post on X:

“Less than 72 hours for ASCO
Exciting science to be presented
New drugs into trials
Biespecific+/- ADC
ADC+ IO
KRASG12D
New small mol KIF18A
More ctDNA and new IA

My TOP 10 for Drug Development BELOW.”

Drug Development

 

Oriol Mirallas previewed the ASCO 2025 conference by highlighting promising innovations in drug development. Key trends include trials featuring bispecifics and ADC combinations, advances targeting KRASG12D, and novel agents like KIF18A inhibitors. He also emphasized increasing focus on ctDNA and immunoanalytics.

You Can Find More Posts Featuring Oriol Mirallas on OncoDaily.

ASCO 2025 ASCO25 cancer drug development OncoDaily Oncology Oriol Mirallas
Special Coverage
Oncolibrary
Jul 11, 2025, 00:41
Hormonal Replacement Therapy in Cancer Survivors: Safety, Benefits, and Clinical Guidelines
Blog
Jul 10, 2025, 21:33
Today Marks the Beginning of Module 1 of the 2nd SIOP Europe Course in Paediatric Oncology
Blog
Jul 10, 2025, 21:24
At AACR25, Douglas Hanahan Showed That IL-1 Family Signaling Drives Systemic Immunosuppression in HPV Cancers
Blog
Jul 10, 2025, 21:13
Raelyn Was Just 4 Years Old When She Was Diagnosed With T-Cell Acute Lymphoblastic Leukemia - St. Baldrick's Foundation
Blog
Jul 10, 2025, 20:58
Janna Sisakyan: I Am Excited to Carry These Lessons Forward in My Future Medical Career
Blog
Jul 10, 2025, 20:44
We’re Excited to Announce That the First Patient Has Been Randomised in the PROLoNG Study - EORTC
Blog
Jul 10, 2025, 20:32
Paolo Tarantino: Incredibly Excited to Co-Chair the NRG Oncology Summer Symposium 2025
Blog
Jul 10, 2025, 20:21
Joshua Brody: Crystal-Clear Update on Treating Aggressive Lymphomas
Insight
Jul 10, 2025, 20:08
Pashtoon Kasi: The 1st Agnostic Study of a PARP Inhibitor
Drugs
Jul 10, 2025, 16:59
Taletrectinib (Ibtrozi): What Patients Should Know About in 2025?
Blog
Jul 10, 2025, 16:30
Indiana’s First Mobile Lung Screening Unit Proves That Access to Care Saves Lives - IU Simon Comprehensive Cancer Center
Blog
Jul 10, 2025, 16:24
Herbert Loong: Had an Opportunity to Introduce and Discuss Soft Tissue Sarcomas at Radio Television Hong Kong